We are live on ! Find out more

923 hedge funds and large institutions have $17.9B invested in Labcorp in 2024 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 342 increasing their positions, 337 reducing their positions, and 90 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more funds holding in top 10

Funds holding in top 10: 79 (+2)

24% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 90

2.21% more ownership

Funds ownership: 90.92%93.13% (+2.2%)

5% more capital invested

Capital invested by funds: $17B → $17.9B (+$841M)

1% more repeat investments, than reductions

Existing positions increased: 342 | Existing positions reduced: 337

1% more funds holding

Funds holding: 918923 (+5)

29% less call options, than puts

Call options by funds: $48.5M | Put options by funds: $68.4M

Holders
923
Holders Change
+5
Holders Change %
+0.54%
% of All Funds
12.16%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.12%
New
112
Increased
342
Reduced
337
Closed
90
Calls
$48.5M
Puts
$68.4M
Net Calls
-$19.9M
Net Calls Change
-$8.33M
Name Holding Trade Value Shares
Change
Change in
Stake
GT
51
Glenmede Trust
Pennsylvania
$65.7M -$2.04M -8,871 -3%
CI
52
Cambiar Investors
Colorado
$61.6M -$1.65M -7,192 -3%
Wellington Management Group
53
Wellington Management Group
Massachusetts
$60.4M -$14.6M -63,449 -19%
Lazard Asset Management
54
Lazard Asset Management
New York
$58.2M +$6.96M +30,325 +14%
Swiss National Bank
55
Swiss National Bank
Switzerland
$54.4M -$2.98M -13,000 -5%
WIM
56
Weitz Investment Management
Nebraska
$54.2M -$40.1K -175 -0.1%
Goldman Sachs
57
Goldman Sachs
New York
$53.3M -$28.2M -122,990 -35%
FCIM
58
Fairview Capital Investment Management
California
$51.8M +$913K +3,978 +2%
SEI Investments
59
SEI Investments
Pennsylvania
$51.2M +$5.65M +24,616 +12%
N
60
Nuveen
North Carolina
$49.9M -$121M -527,411 -71%
FGP
61
Freestone Grove Partners
California
$48.7M +$48.7M +212,335 New
BCWM
62
Bartlett & Co Wealth Management
Ohio
$48.4M -$169K -736 -0.3%
AAM
63
AMI Asset Management
California
$46.9M -$1.1M -4,807 -2%
CS
64
Cannell & Spears
New York
$46.4M +$7.4M +32,259 +19%
Ameriprise
65
Ameriprise
Minnesota
$44.3M -$1.74M -7,564 -4%
Sumitomo Mitsui Trust Group
66
Sumitomo Mitsui Trust Group
Japan
$43.6M +$408K +1,779 +0.9%
NC
67
Nicholas Company
Wisconsin
$42.3M
BNP Paribas Financial Markets
68
BNP Paribas Financial Markets
France
$39.3M +$10.3M +44,702 +35%
Janus Henderson Group
69
Janus Henderson Group
United Kingdom
$38.1M -$3.87M -16,861 -9%
HSBC Holdings
70
HSBC Holdings
United Kingdom
$37.2M -$3.42M -14,896 -8%
TSW
71
Thompson Siegel & Walmsley
Virginia
$36.5M -$36.6M -159,362 -50%
DIA
72
Davidson Investment Advisors
Montana
$36.4M -$82.4K -359 -0.2%
National Pension Service
73
National Pension Service
South Korea
$35.1M -$1.33M -5,800 -4%
AQR Capital Management
74
AQR Capital Management
Connecticut
$34.7M -$24.1M -105,181 -41%
Raymond James Financial
75
Raymond James Financial
Florida
$33.8M +$33.8M +147,302 New

LH Hedge Fund Activity: Q4 2024 in Review

923 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Labcorp (LH) for Q4 2024, worth a combined $17.9B — up 4.9% from $17B a quarter earlier.

Buyers outnumbered sellers: 112 funds opened new LH positions and 90 closed out — a net gain of 22 holders — while 342 added to existing stakes and 337 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $297M. The largest seller was JP Morgan Chase, cutting an estimated $134M.

  • 923 institutional investors held Labcorp (LH) as of Q4 2024, up from 918 in Q3 2024.
  • Funds reported $17.9B of Labcorp stock for Q4 2024, up 4.9% quarter-over-quarter.
  • 112 funds opened new Labcorp positions in Q4 2024 and 90 closed out, a net change of +22 holders.
  • The largest Labcorp buyer in Q4 2024 was Citadel Advisors, an estimated $297M added.
  • The largest Labcorp seller in Q4 2024 was JP Morgan Chase, an estimated $134M sold.

Based on aggregated 13F filings for Q4 2024.